312 related articles for article (PubMed ID: 36338891)
21. The Impact of Liver Chemistries on Respiratory Failure among Hemodialysis Patients with COVID-19 during the Omicron Wave.
Hori M; Yasuda K; Takahashi H; Aoi T; Mori Y; Tsujita M; Shirasawa Y; Kondo C; Hashimoto T; Koyama H; Morozumi K; Maruyama S
Intern Med; 2023 Sep; 62(18):2617-2625. PubMed ID: 37407459
[TBL] [Abstract][Full Text] [Related]
22. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
Frager SZ; Szymanski J; Schwartz JM; Massoumi HS; Kinkhabwala M; Wolkoff AW
Hepatol Commun; 2021 Mar; 5(3):424-433. PubMed ID: 33681677
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
[TBL] [Abstract][Full Text] [Related]
25. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
[TBL] [Abstract][Full Text] [Related]
26. Elevated Transaminases as Predictors of COVID-19 Pneumonia Severity.
Radonjić T; Milićević O; Jovanović I; Zdravković M; Dukić M; Mandić OM; Bjekić-Macut J; Marković OB; Todorović Z; Brajković M; Nikolić N; Klašnja S; Popadić V; Divac A; Marinković M; Alhayek N; Branković MS
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888561
[TBL] [Abstract][Full Text] [Related]
27. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
28. Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.
Fu Y; Zhu R; Bai T; Han P; He Q; Jing M; Xiong X; Zhao X; Quan R; Chen C; Zhang Y; Tao M; Yi J; Tian D; Yan W
Hepatology; 2021 Apr; 73(4):1509-1520. PubMed ID: 32602604
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection.
Zou X; Fang M; Li S; Wu L; Gao B; Gao H; Ran X; Bian Y; Li R; ShanshanYu ; Ling J; Li D; Tian D; Huang J
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):597-603. PubMed ID: 32553907
[TBL] [Abstract][Full Text] [Related]
32. Acute Liver Injury in Patients Hospitalized with COVID-19.
Sobotka LA; Esteban J; Volk ML; Elmunzer BJ; Rockey DC;
Dig Dis Sci; 2022 Aug; 67(8):4204-4214. PubMed ID: 34487314
[TBL] [Abstract][Full Text] [Related]
33. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
[No Abstract] [Full Text] [Related]
35. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
36. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.
Garrido M; Pereira Guedes T; Alves Silva J; Falcão D; Novo I; Archer S; Rocha M; Maia L; Sarmento-Castro R; Pedroto I
GE Port J Gastroenterol; 2021 Jan; 158(4):1-12. PubMed ID: 34192127
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
Liao FL; Peng DH; Chen W; Hu HN; Tang P; Liu YY; Luo Y; Yao T
J Med Virol; 2021 Apr; 93(4):2365-2373. PubMed ID: 33314141
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
39. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study.
Wang J; Zhu L; Xue L; Liu L; Yan X; Yan X; Huang S; Zhang B; Xu T; Li C; Ji F; Ming F; Zhao Y; Cheng J; Shao H; Chen K; Zhao XA; Sang D; Zhao H; Guan X; Chen X; Chen Y; Liu J; Huang R; Zhu C; Wu C
J Med Virol; 2021 Jun; 93(6):3305-3311. PubMed ID: 33174624
[TBL] [Abstract][Full Text] [Related]
40. Mild versus Severe Liver Injury in SARS-CoV-2 Infection.
Anastasiou OE; Korth J; Herbstreit F; Witzke O; Lange CM
Dig Dis; 2021; 39(1):52-57. PubMed ID: 32777784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
